Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) is a publicly traded Healthcare sector company. As of August 17, 2026, CANF trades at $3.41 with a market cap of $7.28M and a P/E ratio of 0.00. CANF moved +0.15% today. Year to date, CANF is -15.00%; over the trailing twelve months it is -74.70%. Its 52-week range spans $2.56 to $46.60. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces CANF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CANF, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.41 |
| Market Cap | $7.28M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.60 |
| 52-Week Low | $2.56 |
| Volume | 69.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover CANF: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.